SCHEMBL30714726

SCHEMBL30714726

COCC(C)(CO)NC(=O)c1c2cc(OCc3ccccn3)ccc2nn1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMO Q99835 5/20 0.39
MAPK14 Q16539 4/20 0.39
CYP2C9 P11712 2/20 0.38
KCNH2 Q12809 1/20 0.38
PDE5A O76074 6/20 0.37
PDE4A P27815 6/20 0.37
PDE4B Q07343 6/20 0.37
PDE4C Q08493 6/20 0.37
PDE4D Q08499 6/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
ALOX12 P18054 1/20 0.37
NFKB1 P19838 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PDE3B Q13370 2/20 0.37
PDE3A Q14432 2/20 0.37
PARP10 Q53GL7 1/20 0.36
APP P05067 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26869335 1.00 SMO (0.39) SMOMAPK14CYP2C9KCNH2PDE5A
SCHEMBL30714664 0.94 SMO (0.41) SMOMAPK14CYP2C9KCNH2PDE5A
SCHEMBL26871154 0.90 SMO (0.37) SMOMAPK14CYP2C9KCNH2PDE5A
SCHEMBL26869323 0.90 SMO (0.39) SMOMAPK14CYP2C9KCNH2PDE5A
SCHEMBL26868364 0.88 SMO (0.38) SMOMAPK14CYP2C9KCNH2PDE5A
SCHEMBL26868963 0.86 SMO (0.40) SMOMAPK14CYP2C9KCNH2PDE5A
SCHEMBL30714591 0.85 PARP10 (0.41) SMOMAPK14CYP2C9KCNH2PDE5A
SCHEMBL26869163 0.84 SMO (0.39) SMOMAPK14CYP2C9KCNH2PDE5A
SCHEMBL26868978 0.82 GUCY1B2 (0.43) SMOMAPK14CYP2C9KCNH2
SCHEMBL26696087 0.82 SMO (0.37) SMOMAPK14CYP2C9KCNH2PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119968362-A Indazole derivatives for the treatment of TRPM3 mediated disorders 勒芬天主教大学 2025-05-09 CN disclosed
EP-4499624-A2 INDAZOLE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-02-05 EP disclosed
WO-2023230540-A2 INDAZOLE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed